Associate Professor Shankar Siva is a radiation oncologist at Icon Cancer Centre onsite at Mulgrave. He completed his PhD with the Molecular Radiation Biology at the internationally renowned Peter MacCallum Cancer Centre, focusing on translational investigations in precision high-dose lung radiotherapy.
He has over 100 peer reviewed manuscript publications including the the first original research from Australia on the use of stereotactic body radiotherapy. He has been recognised by his peers with over 20 prizes for research in the field of oncology.
Shankar leads multiple clinical trials in the treatment of lung and urological cancers and is chair of multiple TransTasman Radiation Oncology Group (TROG) studies in the fields of oligometastases, lung, spine and kidney cancers. He is Co-Chair of the TROG Genitourinary Group and is a member of the Management Advisory Committee (MAC) of the Australasian Lung Cancer Trials Group (ALTG) amongst other leadership roles.
He has an international profile in advanced radiotherapy techniques, and is regularly invited to present at national and international scientific meetings in this field.